Insider Activity Highlights a Strategic Shift at Genworth
On February 13 2026, CareScout Ins. President and CEO Andrea Lynn White executed a sizable Restricted Stock Unit (RSU) vesting that translated into 21,892 shares of Genworth’s common stock. Although the transaction involved no cash—RSUs settled on a 1:1 basis—White’s post‑transaction holding rose to 690,147 shares, underscoring a long‑term stake that aligns with Genworth’s broader governance strategy. The same day, White sold 6,076 shares at an average price of $8.92, a modest 0.02 % discount to the market, reflecting routine tax‑withholding mechanics rather than an intent to divest.
The move is part of a broader insider buying wave. EVP & CFO Jerome Upton purchased 36,486 shares, while EVP & CIO Kelly Saltzgaber bought 21,892 shares. Both insiders also sold a smaller fraction of shares at $8.92, mirroring the tax‑withholding pattern seen with White. EVP & Risk Officer Mark Blakeley and EVP & HR Officer Melissa Hagerman added roughly 21,892 shares each. These coordinated purchases suggest confidence in Genworth’s near‑term valuation and a belief that the $9.00 close represents an undervaluation relative to the company’s $9.28 52‑week high.
What This Means for Investors
The collective insider buying—amounting to roughly 108,000 shares across four executives—signals a bullish outlook that could buoy market sentiment, particularly after a 2.21 % weekly decline. Given Genworth’s price‑to‑earnings ratio of 15.27, insiders are betting the stock will rebound toward its December high. The 83.83 % social media buzz, coupled with a negative sentiment score of –46, indicates heightened attention but not widespread pessimism. Investors may view the insider activity as a positive catalyst, especially if the company can translate its insurance and wealth‑management offerings into higher earnings.
Implications for Genworth’s Future
Genworth’s diversified portfolio—life, long‑term care, and mortgage‑guarantee insurance—positions it well for a recovering insurance market. The insider purchases may signal upcoming strategic initiatives, such as expansion into new geographic markets or product lines, that require additional capital and shareholder confidence. If Genworth can sustain earnings growth, the stock may close the gap between its current price and the 52‑week high, potentially restoring investor enthusiasm that has cooled after a modest decline.
Conclusion
Andrea Lynn White’s RSU vesting, coupled with the coordinated buying by key executives, paints a picture of insider confidence amid modest market volatility. For investors, this activity provides a useful barometer of internal sentiment and could foreshadow a rebound as Genworth continues to leverage its core insurance strengths in a competitive landscape.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-02-13 | White Andrea Lynn (Pres. & CEO, CareScout Ins.) | Buy | 21,892.00 | 0.00 | Common Stock |
| 2026-02-13 | White Andrea Lynn (Pres. & CEO, CareScout Ins.) | Sell | 6,076.00 | 8.92 | Common Stock |
| 2026-02-13 | White Andrea Lynn (Pres. & CEO, CareScout Ins.) | Sell | 21,892.00 | N/A | Restricted Stock Units |
| 2026-02-13 | Upton Jerome T (EVP & Chief Financial Officer) | Buy | 36,486.00 | 0.00 | Common Stock |
| 2026-02-13 | Upton Jerome T (EVP & Chief Financial Officer) | Sell | 9,701.00 | 8.92 | Common Stock |
| 2026-02-13 | Upton Jerome T (EVP & Chief Financial Officer) | Sell | 36,486.00 | N/A | Restricted Stock Units |
| 2026-02-13 | Saltzgaber Kelly A (EVP & Chief Investment Officer) | Buy | 21,892.00 | 0.00 | Common Stock |
| 2026-02-13 | Saltzgaber Kelly A (EVP & Chief Investment Officer) | Sell | 6,195.00 | 8.92 | Common Stock |
| 2026-02-13 | Saltzgaber Kelly A (EVP & Chief Investment Officer) | Sell | 21,892.00 | N/A | Restricted Stock Units |
| 2026-02-13 | Karawan Gregory S. (EVP and General Counsel) | Buy | 21,892.00 | 0.00 | Common Stock |
| 2026-02-13 | Karawan Gregory S. (EVP and General Counsel) | Sell | 6,076.00 | 8.92 | Common Stock |
| N/A | Karawan Gregory S. (EVP and General Counsel) | Holding | 4,731.74 | N/A | Common Stock |
| 2026-02-13 | Karawan Gregory S. (EVP and General Counsel) | Sell | 21,892.00 | N/A | Restricted Stock Units |
| 2026-02-13 | Hodges Mark Blakeley (EVP and Chief Risk Officer) | Buy | 21,892.00 | 0.00 | Common Stock |
| 2026-02-13 | Hodges Mark Blakeley (EVP and Chief Risk Officer) | Sell | 7,284.00 | 8.92 | Common Stock |
| N/A | Hodges Mark Blakeley (EVP and Chief Risk Officer) | Holding | 4,526.48 | N/A | Common Stock |
| 2026-02-13 | Hodges Mark Blakeley (EVP and Chief Risk Officer) | Sell | 21,892.00 | N/A | Restricted Stock Units |
| 2026-02-13 | Hagerman Melissa (EVP and Chief HR Officer) | Buy | 21,892.00 | 0.00 | Common Stock |
| 2026-02-13 | Hagerman Melissa (EVP and Chief HR Officer) | Sell | 7,184.00 | 8.92 | Common Stock |
| 2026-02-13 | Hagerman Melissa (EVP and Chief HR Officer) | Sell | 21,892.00 | N/A | Restricted Stock Units |
| 2026-02-13 | Arland Jamala M. (Pres. & CEO, U.S. Life Ins.) | Buy | 10,946.00 | 0.00 | Common Stock |
| 2026-02-13 | Arland Jamala M. (Pres. & CEO, U.S. Life Ins.) | Sell | 3,843.00 | 8.92 | Common Stock |
| 2026-02-13 | Arland Jamala M. (Pres. & CEO, U.S. Life Ins.) | Sell | 10,946.00 | N/A | Restricted Stock Units |




